Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290861 · ClinicalTrials.gov registry record
Cognitive Assessment Battery (CAB) Beta Study
A clinical trial, sponsored by CHDI Foundation.
- Completed
- Registry status
- 255
- Enrollment target
NCT01290861: Completed study, sponsored by CHDI Foundation.
NCT01290861 is a clinical trial that has completed, run by CHDI Foundation. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01290861 has completed, sponsored by CHDI Foundation.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
The overall objective of this study is to identify a 60 minute cognitive battery, for subsequent use in clinical trials, that detects cognitive deficits in early HD and late pre-manifest HD compared to controls, and that has a potential to show drug induced improvements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2011-02 |
What the finished NCT01290861 record still lists
NCT01290861 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01290861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01290861 about?
NCT01290861 is a clinical study titled "Cognitive Assessment Battery (CAB) Beta Study". The overall objective of this study is to identify a 60 minute cognitive battery, for subsequent use in clinical trials, that detects cognitive deficits in early HD and late pre-manifest HD compared to controls, and that has a potential to show drug induced improvements.
What is the current status of trial NCT01290861?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2011-02.
Who is sponsoring clinical trial NCT01290861?
This trial is sponsored by CHDI Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia